about
Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencingTransgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promotersMi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylationFacioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesisAssociation of modified cytosines and the methylated DNA-binding protein MeCP2 with distinctive structural domains of lampbrush chromatinA brain-derived MeCP2 complex supports a role for MeCP2 in RNA processingSMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome.Methylated DNA and MeCP2 recruit histone deacetylase to repress transcriptionA multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPaseMyogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.Histone deacetylase directs the dominant silencing of transcription in chromatin: association with MeCP2 and the Mi-2 chromodomain SWI/SNF ATPase.Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.Relationships between chromatin organization and DNA methylation in determining gene expression.Testing the effects of FSHD candidate gene expression in vertebrate muscle development.Dual functions of thyroid hormone receptors during Xenopus development.Functional analysis of the SIN3-histone deacetylase RPD3-RbAp48-histone H4 connection in the Xenopus oocyte.Muscular dystrophy candidate gene FRG1 is critical for muscle development.Nuclear receptor corepressor recruitment by unliganded thyroid hormone receptor in gene repression during Xenopus laevis developmentIdentifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.Functional CpG methylation system in a social insect.N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors.Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesisIndividual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.Emerging preclinical animal models for FSHD.Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and diseaseThe tripartite motif of nuclear factor 7 is required for its association with transcriptional units.C. elegans PAT-9 is a nuclear zinc finger protein critical for the assembly of muscle attachmentsLarge family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy.Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB.CRISPR/dCas9-mediated Transcriptional Inhibition Ameliorates the Epigenetic Dysregulation at D4Z4 and Represses DUX4-fl in FSH Muscular Dystrophy.Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia.FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.Purification of MeCP2-containing deacetylase from Xenopus laevis.Programming the transcriptional state of replicating methylated dna.Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies.Demethylated HSATII DNA and HSATII RNA Foci Sequester PRC1 and MeCP2 into Cancer-Specific Nuclear Bodies.Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2.
P50
Q24294291-8d2864e5-4f3b-14d0-547b-60af3b1c0d51Q27318439-d729d044-40d0-24d2-e9b2-dd6453023508Q28140428-32965086-4466-a407-3489-4ea39bb4f2edQ28143634-2ba1ac9b-49e8-8617-cd2c-2f33cbdc19ddQ28271204-8318366c-42d5-f2a7-5a1e-5e6e44013da9Q28279223-d696ef39-43b7-3abf-9059-2688e87fbe2aQ28572490-7375973d-4fd7-1671-bf66-4dfc575cbae0Q29465800-78ee45b7-457d-9ff5-48e2-6efc38e333d3Q29547568-dee4de84-44c5-fac6-c0c7-068c3b2d0d4eQ29617070-93622a3d-47ab-67b9-4863-c4f8e41966ebQ33602618-c8f0f9b4-4f65-4d17-3300-0a0896687948Q33671506-ea8bfea2-45b9-0592-a3f5-8b0c7f293ddbQ33748620-27247d31-461c-1409-76de-c0ff3c4f3cc6Q33765668-2ac8ff4e-416b-94cf-2683-a30f9e543be7Q33861089-69a8e3c1-4839-c3c5-2e83-cdc691d27a3cQ33954798-ce6f7029-446e-c8f5-5066-579d25fc7d3cQ33959046-1a1594dd-4bee-e1fb-dcc1-9eccb4877e5cQ34244856-4c308055-4f27-ab8a-0683-b9ca6a52c710Q34443197-d09064e6-4625-a44e-fb38-14db22a40c7dQ34515410-c91aff75-49a9-4fff-2653-ee772b6bd110Q34539583-eb49fba0-4b7a-f96e-7c9c-9fcc01aad792Q34577094-184f4a70-4678-09f2-cbee-0ba9339e8cd5Q35070013-a4aec77d-48f1-172b-5777-0b8b4394f18cQ35127142-5956ea9d-46b0-58ce-0475-7fb1c2a80fceQ35145517-aac00f5e-4016-fe7e-e99d-d48654034970Q35518696-0196d543-4540-dde8-e0a4-7cfe72e6647fQ35582587-5ba9f74d-4000-57ff-c2eb-c414a3204a60Q35608609-15c44b6d-488c-331f-c15a-41afbe239662Q35856743-8d71622a-4a21-d23f-bf72-801ba9f9f9ffQ36165731-1718d5d6-4f86-4b29-7a35-8e4b51a1426aQ36270733-3bce188b-4302-3b80-b407-9f56d502407aQ36573870-07bfd573-44fc-3719-2fe5-0a819efc8204Q36675292-e5f4466e-4991-8c09-e97b-f1430017e101Q36916418-d71f126d-4aa9-adf8-e7ca-b037806bc52fQ37175879-0a54b056-452a-0536-ba87-a244b12e46afQ38290231-986d7171-4e97-2ecc-f2da-1ad64e567739Q38302576-404a8c2b-40c5-b2ab-bc0d-f7fc8e7a2136Q40073212-761bc66c-419e-fa4e-6d5b-ef4de275dc35Q41813113-bb2b4903-4be3-58e6-2e00-a0ddf9bbe8cfQ42071075-70696e5f-44e2-f676-1371-fb9e55cc1a09
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter L Jones
@nl
Peter L. Jones
@en
Peter L. Jones
@es
بيتر إل جونز
@ar
type
label
Peter L Jones
@nl
Peter L. Jones
@en
Peter L. Jones
@es
بيتر إل جونز
@ar
altLabel
Peter L Jones
@en
Peter Lawrence Jones
@en
prefLabel
Peter L Jones
@nl
Peter L. Jones
@en
Peter L. Jones
@es
بيتر إل جونز
@ar
P106
P1153
57199134477
P2038
Peter_Jones26
P31
P496
0000-0003-4283-1016